ロード中...
AT‐RvD1 combined with DEX is highly effective in treating TNF‐α‐mediated disruption of the salivary gland epithelium
Sjögren's syndrome (SS) is an autoimmune disorder characterized by chronic inflammation and destruction of salivary and lacrimal glands leading to dry mouth and dry eyes, respectively. Currently, the etiology of SS is unknown and the current therapies have no permanent benefit; therefore, new a...
保存先:
| 出版年: | Physiol Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064142/ https://ncbi.nlm.nih.gov/pubmed/27694530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.12990 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|